Omeros Corp (OMER)
3.14
+0.08
(+2.61%)
USD |
NASDAQ |
Apr 26, 16:00
3.14
0.00 (0.00%)
After-Hours: 20:00
Omeros Enterprise Value: 218.61M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 218.61M |
| April 24, 2024 | 217.45M |
| April 23, 2024 | 220.35M |
| April 22, 2024 | 219.77M |
| April 19, 2024 | 218.03M |
| April 18, 2024 | 227.30M |
| April 17, 2024 | 234.84M |
| April 16, 2024 | 240.05M |
| April 15, 2024 | 237.15M |
| April 12, 2024 | 259.17M |
| April 11, 2024 | 269.60M |
| April 10, 2024 | 252.22M |
| April 09, 2024 | 240.05M |
| April 08, 2024 | 239.47M |
| April 05, 2024 | 240.05M |
| April 04, 2024 | 222.09M |
| April 03, 2024 | 223.83M |
| April 02, 2024 | 218.03M |
| April 01, 2024 | 226.14M |
| March 28, 2024 | 241.21M |
| March 27, 2024 | 250.37M |
| March 26, 2024 | 252.81M |
| March 25, 2024 | 251.59M |
| March 22, 2024 | 249.14M |
| March 21, 2024 | 265.65M |
| Date | Value |
|---|---|
| March 20, 2024 | 271.76M |
| March 19, 2024 | 260.76M |
| March 18, 2024 | 256.48M |
| March 15, 2024 | 264.43M |
| March 14, 2024 | 266.26M |
| March 13, 2024 | 288.27M |
| March 12, 2024 | 287.66M |
| March 11, 2024 | 298.05M |
| March 08, 2024 | 309.05M |
| March 07, 2024 | 317.61M |
| March 06, 2024 | 310.88M |
| March 05, 2024 | 298.66M |
| March 04, 2024 | 312.72M |
| March 01, 2024 | 333.50M |
| February 29, 2024 | 316.39M |
| February 28, 2024 | 318.22M |
| February 27, 2024 | 316.39M |
| February 26, 2024 | 319.44M |
| February 23, 2024 | 293.16M |
| February 22, 2024 | 295.30M |
| February 21, 2024 | 300.49M |
| February 20, 2024 | 326.17M |
| February 16, 2024 | 340.23M |
| February 15, 2024 | 340.23M |
| February 14, 2024 | 321.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
74.32M
Minimum
Oct 27 2023
1.552B
Maximum
Feb 19 2021
675.41M
Average
722.92M
Median
Oct 02 2020
Enterprise Value Benchmarks
| Ardelyx Inc | 1.334B |
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.27M |
| iBio Inc | 15.86M |
| Theriva Biologics Inc | -13.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.068M |
| Total Expenses (Quarterly) | 39.76M |
| EPS Diluted (Quarterly) | -0.15 |
| Earnings Yield | -59.87% |
| Normalized Earnings Yield | -70.36 |